Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Here's Why Arrowhead Pharmaceuticals Jumped 14.1% in November
Motley Fool
Mon, 12/10/18 - 07:04 pm
Tags:
Arrowhead Pharmaceuticals, ARO-HBV, hepatitis B, Janssen, RNAi
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Mon, 12/3/18 - 09:55 am
Tags:
Argenx, Cilag, Janssen, cusatuzumab, ASH2018, blood cancers
Adaptive Trial Designs: BIO, Janssen, ACRO Call for Tweaks to FDA Draft Guidance
RAPS.org
Sun, 12/2/18 - 12:31 pm
Tags:
clinial trials, adaptive trial design, FDA, BIO, ACRO, Janssen
New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs
BioSpace
Wed, 11/14/18 - 11:42 pm
Tags:
New Jersey, opioids, JNJ, Janssen
Llama antibodies could provide universal flu protection
BioCentury
Thu, 11/1/18 - 07:16 pm
Tags:
Janssen, Scripps Research Institute, flu vaccines, Flu
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Thu, 11/1/18 - 11:31 am
Tags:
Janssen, JNJ, Invokana, type 2 diabetes
Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
CP Wire
Wed, 10/31/18 - 11:03 am
Tags:
Arrowhead Pharmaceuticals, Janssen, JNJ, hepatitis B
Wed, 10/31/18 - 10:25 am
Tags:
Arrowhead Pharmaceuticals, Janssen, JNJ
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
BioSpace
Tue, 10/30/18 - 12:06 pm
Tags:
JNJ, Janssen, Genmab, Darzalex, clinical trials, Multiple Myeloma
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
CP Wire
Tue, 10/30/18 - 10:22 am
Tags:
Janssen, JNJ, Symtuza, HIV
Tue, 10/30/18 - 09:53 am
Tags:
Janssen, JNJ, Symtuza, HIV
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 10:07 am
Tags:
Janssen, JNJ, Stelara, Crohn's Disease, clinical trials
J&J snaps up key label expansion for Xarelto
Biopharma Dive
Mon, 10/15/18 - 12:10 pm
Tags:
JNJ, Xarelto, bloodthinners, Eliquis, Janssen, Bayer
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
Tags:
JNJ, Janssen, Darzalex, daratumumab, Europe, Multiple Myeloma
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
Tags:
FDA, JNJ, Janssen, Lundbeck, Takeda, major depressive disorder, drug development
Janssen, Bayer to close South Korean plants due to limited demand
Fierce Pharma
Sat, 08/4/18 - 12:12 pm
Tags:
drug manufacturing, Bayer, Janssen, South Korea
How rival opioid makers sought to cash in on alarm over OxyContin’s dangers
Stat
Thu, 08/2/18 - 11:18 pm
Tags:
Purdue Pharma, oxycontin, opioids, Janssen
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Wed, 08/1/18 - 11:33 pm
Tags:
Pfizer, Celltrion, JNJ, Janssen, patents, Remicade
Where does J&J's new drug fit in the crowded HIV market?
Biopharma Dive
Wed, 07/18/18 - 09:54 pm
Tags:
JNJ, Janssen, FDA, HIV, Symtuza
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
Tags:
JNJ, Tremfya, MorphoSys, Janssen, Crohn's Disease, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.